Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Perotti

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Archives of Medical Research|May 28, 2024
Serendipitous Adrenal Hyperplasia in Patients Admitted to the Emergency Department for Suspected SARS-CoV-2 Infection is Linked to Increased MortalityGiuseppe Reimondo, Federica Solitro, Soraya Puglisi, et al.
Bioinformation|December 18, 2007
Neuroendocrine immunity in patients with Alzheimer's disease: toward translational epigeneticsFrancesco Chiappelli, Paolo Prolo, Kristine D Cajulis, et al.
European Journal of Endocrinology|October 23, 2019
Activity and safety of temozolomide in advanced adrenocortical carcinoma patientsDeborah Cosentini, Giuseppe Badalamenti, Salvatore Grisanti, et al.
Journal of Personalized Medicine|April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered QuestionVittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
Journal of Clinical Medicine|November 6, 2019
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant TreatmentSoraya Puglisi, Anna Calabrese, Vittoria Basile, et al.
Cancers|April 5, 2020
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical CarcinomaSoraya Puglisi, Anna Calabrese, Vittoria Basile, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2023
New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort StudySoraya Puglisi, Anna Calabrese, Francesco Ferraù, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2019
Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical CarcinomaVasileios Chortis, Irina Bancos, Thomas Nijman, et al.
The Lancet. Diabetes & Endocrinology|August 24, 2023
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational studyMassimo Terzolo, Martin Fassnacht, Paola Perotti, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Archives of Medical Research|May 28, 2024
Serendipitous Adrenal Hyperplasia in Patients Admitted to the Emergency Department for Suspected SARS-CoV-2 Infection is Linked to Increased MortalityGiuseppe Reimondo, Federica Solitro, Soraya Puglisi, et al.
Bioinformation|December 18, 2007
Neuroendocrine immunity in patients with Alzheimer's disease: toward translational epigeneticsFrancesco Chiappelli, Paolo Prolo, Kristine D Cajulis, et al.
European Journal of Endocrinology|October 23, 2019
Activity and safety of temozolomide in advanced adrenocortical carcinoma patientsDeborah Cosentini, Giuseppe Badalamenti, Salvatore Grisanti, et al.
Journal of Personalized Medicine|April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered QuestionVittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
Journal of Clinical Medicine|November 6, 2019
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant TreatmentSoraya Puglisi, Anna Calabrese, Vittoria Basile, et al.
Cancers|April 5, 2020
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical CarcinomaSoraya Puglisi, Anna Calabrese, Vittoria Basile, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2023
New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort StudySoraya Puglisi, Anna Calabrese, Francesco Ferraù, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2019
Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical CarcinomaVasileios Chortis, Irina Bancos, Thomas Nijman, et al.
The Lancet. Diabetes & Endocrinology|August 24, 2023
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational studyMassimo Terzolo, Martin Fassnacht, Paola Perotti, et al.
Pageof 3